C-MER Medical Schedules 20 May 2026 AGM; Board Proposes HK3.0 Cents Total Dividend and Renewal of Share Mandates

Bulletin Express
04/17

C-MER Medical Holdings Limited has issued a notice convening its annual general meeting (AGM) for 20 May 2026 at 5:00 p.m. in Central, Hong Kong.

Key agenda items:

1. Financial statements • Shareholders will be asked to receive and consider the audited consolidated results for the year ended 31 December 2025 together with the reports of the directors and auditor PricewaterhouseCoopers.

2. Dividend distribution • Final dividend: HK2.0 cents per share. • Special dividend: HK1.0 cent per share. • The register of members will be closed from 2 July 2026 to 6 July 2026; shares must be lodged for registration by 4:30 p.m. on 30 June 2026 to qualify for the dividends.

3. Board composition • Five independent non-executive directors—Dr. Rex Auyeung Pak-kuen, Dr. Ko Wing Man, Mr. Ma Andrew Chiu Cheung, Mr. Ip Shu Kwan Stephen and Mr. Li Ling Cheung Raymond—are standing for re-election. • The board will also seek authority to determine directors’ remuneration.

4. Auditor • Re-appointment of PricewaterhouseCoopers as external auditor and authorisation for the board to fix its remuneration.

5. Share mandates • Share repurchase mandate: authority to buy back up to 10% of issued shares during the mandate period. • Issuance mandate: authority to allot, issue or otherwise deal with shares up to 20% of issued share capital. • Extension mandate: the issuance limit can be increased by the number of shares repurchased, capped at an additional 10%.

Administrative details:

• Shareholders wishing to vote at the AGM must be on the register by 4:30 p.m. on 14 May 2026; the register will be closed from 15 May 2026 to 20 May 2026. • Proxy forms must be lodged with Computershare Hong Kong Investor Services Limited by 5:00 p.m. on 18 May 2026.

As of the notice date, the board comprises eight directors, including two executive directors, the chairman and six other independent non-executive directors.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10